The recent approval of several swine flu vaccines by top pharmaceutical companies will benefit industries associated with the swine flu virus.

Top pharmaceutical company Vanguard Pharmaceuticals has recently been expanding its operations into the Latin and South American Markets, with effects that could be beneficial for the distribution of a swine flu vaccine.

Top pharmaceutical sales company Vanguard Pharmaceuticals has the possibility of acquiring a sales contact for the recently developed swine flu vaccine.

With the Swine Flu Virus now a global pandemic and other top biotech companies developing a swine flu vaccine, Vanguard Pharmaceutical’s has been recruited to distribute and promote a natural alternative to these scientific solutions.

Crucell NV is currently developing the only adjuvanted flu vaccine against the influenza virus licensed for all age groups but Crucell stock hasn’t match analyst expectations showing a 20% increase since April 2009.

Since the first swine flu symptoms invaded the media, Antigenics share price has increased 300%, not because of their relationship to the swine flu virus but because of the expectation of Oncophage Antigenics, the cancer vaccine. The first flu vaccine containing their patented QS21 adjuvant could reach the market and provide revenues to Antigenic by 2012.

With their innovative and top selling product, the PFL N95 mask, currently meets both WHO and CDC protection levels in order to project individuals from the spreads of the influenza virus from individuals suffering the swine flu symptoms. Alpha Pro Tech share price has increased 250% since April 2009. More to come?

Although not currently linked with research and development for products directly related to the H1N1 virus, Advanced Life Sciences has a promising pipeline of clinical and preclinical products related to respiratory infections which is the most common complication of the swine flu virus.

With their best seller Quidel Influenza Test, Quidel Corp. share price has increased over 80% since April 2009. Recognized as one of the best distributors of the top pharmaceutical companies, Quidel Corp. is looking to emerge as a leading player in the early detection of one of the fastest growing epidemics, the swine flu.

Sinovac Biotech is one of the top pharmaceutical companies that has a swine flu vaccine being tested with possible production starting in September. Since the first swine flu symptoms were reported in Mexico in April 2009, Sinovac Biotech stock has jumped over 200% exceeding analyst expectations. How much higher can Sinovac Biotech share price go?